Capital Biotech LLP

Appointment

Genomics & Proteomics Solutions

Capital Biotech LLP Services Pathology Genomics & Proteomics Solutions

Advanced Genomics & Proteomics Solutions

Capital Biotech LLP offers cutting-edge platforms for genomics and proteomics profiling. We provide next-generation sequencing services, mass spectrometry tools, and bioinformatic support to help you unravel the complexities of the genome and proteome.

Our multidisciplinary team of geneticists and bioinformaticians leverages the latest technology to deliver actionable insights. We strongly believe that high-throughput omics analysis is reshaping personalized medicine and advanced biology. Our comprehensive workflows are fully validated to ensure deep, accurate, and reproducible molecular characterizations.

Next-Gen Sequencing

Our NGS platforms deliver high-throughput, paired-end sequencing with exceptional read quality for whole-genome, exome, and targeted panel studies.

Protein Identification

We use high-resolution mass spectrometry for comprehensive protein identification, quantification, and post-translational modification analysis.

Bioinformatics Analysis

Our in-house bioinformatics team processes and annotates genomic and proteomic datasets, delivering ready-to-publish results with full statistical support.

Benefits of Genomics & Proteomics Solutions

Capital Biotech LLP provides cutting-edge omics platforms that empower biomarker discovery, drug target identification, and personalized medicine research.

  • High-depth WGS, WES, and RNA-Seq services for comprehensive genomic insights
  • Label-free and label-based (TMT/iTRAQ) quantitative proteomics workflows
  • Validated bioinformatics pipelines meeting global publication standards
  • End-to-end support from sample preparation through to data interpretation

Frequently asked questions

At Capital Biotech LLP, we prioritize transparency and precision. Here are some of the most common questions our clients ask regarding our testing capabilities, turnaround times, and quality assurance protocols.

We utilize Illumina short-read sequencing for high-throughput whole-genome, whole-exome, and RNA-Seq applications, as well as Oxford Nanopore Technology for long-read sequencing when structural variant analysis or direct RNA sequencing is required.

We support label-free and label-based (TMT and iTRAQ) quantitative proteomics, phosphoproteomics, glycoproteomics, and interactomics studies using high-resolution LC-MS/MS platforms, delivering confident protein identification and quantification.

Our standard genomics service includes raw FASTQ files, aligned BAM files, quality control reports, variant call format (VCF) files, and annotated variant tables. Custom downstream analyses including pathway enrichment and population genetics studies can be provided on request.